Page last updated: 2024-09-05

gr 144053 and mci 9038

gr 144053 has been researched along with mci 9038 in 2 studies

Compound Research Comparison

Studies
(gr 144053)
Trials
(gr 144053)
Recent Studies (post-2010)
(gr 144053)
Studies
(mci 9038)
Trials
(mci 9038)
Recent Studies (post-2010) (mci 9038)
21121,08783349

Protein Interaction Comparison

ProteinTaxonomygr 144053 (IC50)mci 9038 (IC50)
ProthrombinHomo sapiens (human)0.22

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collen, D; Kozawa, O; Matsuno, H; Matsuo, O; Uematsu, T; Ueshima, S1
Kozawa, O; Matsuno, H; Matsuo, O; Okada, K; Uematsu, T; Ueshima, S1

Other Studies

2 other study(ies) available for gr 144053 and mci 9038

ArticleYear
Lack of tPA significantly affects antithrombotic therapy by a GPIIb/IIIa antagonist, but not by a thrombin inhibitor in mice.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:4

    Topics: Animals; Arginine; Bleeding Time; Carotid Artery Thrombosis; Dose-Response Relationship, Drug; Fibrinolytic Agents; Mice; Mice, Knockout; Pipecolic Acids; Piperazines; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator

2000
Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2

    Topics: alpha-2-Antiplasmin; Animals; Arginine; Bleeding Time; Blood Coagulation; Carotid Artery Injuries; Endothelium, Vascular; Mice; Mice, Inbred C57BL; Mice, Knockout; Pipecolic Acids; Piperazines; Piperidines; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombin Time; Thrombosis; Vascular Patency

2002